CEO says Novartis will focus on smaller deals in vaccines, generics

02/26/2010 | Reuters · Wall Street Journal, The

Novartis CEO Joe Jimenez said the company will concentrate on smaller, bolt-on acquisitions to expand its businesses in vaccines, generic drugs and consumer health. The Swiss drugmaker's shift in strategy comes after it agreed to pay Nestle $39.3 billion for a controlling stake in eye-care company Alcon.

View Full Article in:

Reuters · Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA